JURA Bio

JURA Bio, Inc. is a pioneering preclinical genomic medicine development company with the mission of improving the efficacy, safety, and time-to-development of genomic medicines. Its platform merges probabilistic machine learning and synthetic biology to design, build and learn from the world’s largest physical libraries of immune receptors and their targets.